Marshall Wace’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Marshall Wace’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,103,054	Closed	-$10.9M	–	3783
2022 Q3	$10.9M	Buy	1,103,054 +100,000	+10%	+$986K	0.02%	821
2022 Q2	$9.82M	Hold	1,003,054	–	–	0.02%	889
2022 Q1	$9.81M	Buy	1,003,054 +72,325	+8%	+$706K	0.02%	885
2021 Q4	$9.12M	Buy	930,729 +227,919	+32%	+$2.22M	0.02%	923
2021 Q3	$6.84M	Buy	702,810 +700	+0.1%	+$6.78K	0.03%	774
2021 Q2	$6.8M	Buy	+702,110	New	+$6.83M	0.03%	674

Marshall Wace's SHAC Position: Q4 2022 in Review

Marshall Wace sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 1,103,054 shares — an estimated $10.9M sold.

Marshall Wace first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $10.9M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Marshall Wace reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 1,103,054 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $10.9M.
Marshall Wace first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
Marshall Wace's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $10.9M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.